The Latest Breaking News from biotechnology

The International Lingayat Youth Forum (ILYF) will hold a three-day Veershaiva Lingayat Global Business Conclave from January 23 to 25 at the Biotechnology Auditorium of BVB College of Engineering and Technology in Hubballi.

The biotech industry is thriving amid innovation, demand, adaptability, and technological advancements, demonstrating resilience and adaptability. So, it could be wise to invest in quality biotech stocks Protalix BioTherapeutics (PLX), Alnylam Pharmaceuticals (ALNY), and Jazz Pharmaceuticals (JAZZ). Read on.

Thermo Fisher Scientific and the Centre for Cellular and Molecular Platforms (C-CAMP) recently announced a collaborative initiative to establish a Centre of Excellence in Bengaluru. This state-of-the-art facility will serve as a hub for fostering innovation, accelerating breakthroughs in the biotechnology sector and enabling researchers to enhance their expertise and…

The biotechnology industry is experiencing significant growth, fueled by rising technological innovations and government support. Therefore, it could be wise to consider fundamentally strong biotech stocks Genfit (GNFT), Equillium (EQ), and Innoviva (INVA) for 2024. Read more.

The biotech industry's dynamic growth, spurred by government backing and technological advances, addresses rising disease challenges and propels advancements in healthcare. Hence, fundamentally strong biotech stocks Gilead Sciences (GILD), Incyte Corporation (INCY), Jazz Pharmaceuticals (JAZZ), and Exelixis (EXEL) might be solid investments for upcoming year gains. Read more….

The biotechnology industry is experiencing significant growth, fueled by recent breakthroughs in drug development, technological innovations, and robust government support. Given this backdrop, promising biotech stocks Shionogi & Co. (SGIOY), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), and United Therapeutics Corporation (UTHR) could be solid buys for 2024 success. Also, these…

A recent study published in Nature describes an AI-driven advancement in biotechnology with implications for medication discovery, disease diagnosis, and environmental monitoring. Read further on Dynamite News:

The biotechnology industry is flourishing due to the recent breakthroughs in drug development, technological advancements, and strong governmental backing. Given this backdrop, promising biotech stocks Organogenesis Holdings (ORGO), Theratechnologies (THTX), and Vertex Pharmaceuticals (VRTX) could be solid buys to supercharge the portfolios. Read on….

A state-of-the-art bio-safety level-3 (BSL-3) laboratory for research on viruses with high potential for life-threatening diseases has begun functioning under Rajiv Gandhi Centre for Biotechnology (RGCB).